Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 19, 2019
Standard myeloma treatment reveals itself as an immunotherapy
Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments
Models aren’t just pretty
From the Schiffer lab, Vaccine and Infectious Disease Division
Nanoparticles open doors to cancer-fighting CAR T cells
Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy
MAIT cells get around
From the Prlic Laboratory, Vaccine and Infectious Disease Division
Could CC-Rix mice change how we think about traditional mouse models?
From the Lund Laboratory, Vaccine and Infectious Disease Division
How the immune system’s key organ regenerates itself
Watch: Hutch researcher discusses harnessing the thymus’s knack for self-repair to boost immune function and help patients
Donor MAIT cells take possession
From the Turtle and Fredricks Laboratories, Vaccine and Infectious Disease Division and Clinical Research Division
The tumor microenvironment: How cancer fools healthy neighboring cells
‘Tumor microenvironment’ research underscores why we need cancer immunotherapy — and how to make it work for more patients
Dissolving implant could bring immunotherapy to solid tumors
A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study
‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
Fred Hutch opens first-of-its kind Bezos Family Immunotherapy Clinic
Clinic will allow researchers to conduct twice as many immunotherapy trials, enable intensive patient monitoring to improve experimental therapies
Patients with advanced lymphoma in remission after T-cell therapy
New study: 7 of 11 trial participants who got two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission
Investing in the future: 5 researchers benefit from President’s Young Investigator Awards
Five researchers get surprise grants through new President’s Young Investigator Awards
Dramatic remissions seen in immunotherapy trial of blood cancer patients
Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
Therapy using engineered immune cells offers promise for the ‘disease that desperately needs something new’
Scratching the surface of a rare skin cancer
Immune-boosting therapy shows promise for advanced Merkel cell carcinoma
An easy pairing
Fred Hutch’s Harlan Robins develops a new method to match thousands of pairs of key genes needed for cancer immunotherapy
HIV vaccine: Could a few special cells help protect millions of people?
New analysis finds rare immune cells linked to HIV vaccine’s effectiveness